[ad_1]
Original title: AstraZeneca vaccine is discontinued in more and more countries with adverse reaction rates that far exceed other vaccines
Overseas Network, March 15 On the 14th local time, the Irish Department of Health announced the suspension of the use of the Oxford / AstraZeneca vaccines to prevent thrombosis. On the same day, following the death of a teacher in Piedmont, Italy, the same Oxford / AstraZeneca vaccination batch was discontinued. In recent days, more and more countries have totally or partially suspended the vaccine.
According to the French television network BFM, there have been deaths from severe thrombosis in Austria, Denmark, Italy and other countries. The deceased had been vaccinated with Oxford / AstraZeneca in the previous days. Although there is no evidence that the death of the patient is related to the injection of the vaccine, as a preventive measure, Austria, Estonia, Latvia, Luxembourg, Lithuania, Italy and other European countries have announced the suspension of the suspected batch of the vaccine. vaccine. On the 11th of this month, Denmark, Iceland and Norway announced the suspension of the use of the Oxford / AstraZeneca vaccines. On the 12th, Bulgaria announced the suspension of the use of the Oxford / AstraZeneca vaccines. On the 13th, Congo announced the postponement of the vaccination campaign that was originally scheduled for the 15th. On the 14th, Ireland also suspended the use of the vaccine and the Italian region of Piedmont announced the suspension of the corresponding batch of vaccine.
On the 13th, three more doctors in Norway were sent to hospital due to severe blood clots or brain congestion. It is not currently known if it is related to the Oxford / AstraZeneca vaccine. The health department is investigating. According to the Norwegian Medicines Agency, he has also received reports of skin bleeding or ecchymosis in some young people after vaccination, which may be due to a sharp drop in platelets. The agency recommends that people under the age of 50 who have side effects that persist for three days after vaccination consult a doctor.
AstraZeneca Pharmaceuticals responded on day 12 that “there is no evidence” that the vaccine developed in cooperation with the University of Oxford increases the risk of thrombosis. But this cannot dispel doubts about the vaccine product, and the number of countries discontinuing the Oxford / AstraZeneca vaccine is increasing by the day.
Countries like France, UK, and Spain are still vaccinating the Oxford / AstraZeneca vaccine. France’s National Medicines Safety Administration issued a report on the night of the 13th to explain that since February 9, 316,800 doses of the same batch of products have been shipped to France that were discontinued in Austria, but there were no deaths in the adverse reaction. injection staff report No life-threatening cases, no cases of thrombosis and thrombocytopenia Based on available data, there is no evidence that these side effects are related to vaccination.
According to a report from the French National Agency for Drug Safety, as of day 4, France had injected 454,545 doses of the Oxford / AstraZeneca vaccine. There were “only” 3013 cases of adverse reactions, representing about 0.66%, including fever and fatigue, and pain at the injection site., Gastrointestinal complaints such as nausea or vomiting, nervous system adverse reactions such as pain in head or dizziness, 68% of which are mild and short-lived adverse reactions, and 964 cases are serious adverse reactions. Although the 0.66% ratio does not appear to be high, it is still much higher than the other two vaccines used in France. Adverse reactions from the Pfizer vaccine in the United States accounted for 0.19% and the Modena vaccine was 0.12%. . (Overseas Network-Paris-Lu Jia)
